ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

Joint Ventures Abroad-Disputed Cost-Benefit

August 21, 1971 profits between production of drugs and that of other items is not going to be simple. Under the price control scheme, the allocation is left to the companies subject to certification by their auditors. Significantly, the companies are not required to show the results of their operations in drugs and of those hi other lines separately in their published accounts. In the circumstances, the public will have to he, it seems, content with general explanations concerning the high profitability of non-pharmaceutical operations.

To read the full text Login

Get instant access

New 3 Month Subscription
to Digital Archives at

₹826for India

$50for overseas users


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top